Upstream Manufacturing Webinars
-
Culturing And Characterizing Organoids And Cancer Spheroids
4/19/2024
Discover techniques for generating, maintaining, and performing high-throughput analysis of organoids and other 3D culture systems that are essential for cutting-edge regenerative medicine research.
-
Optimizing Perfusion Parameters For Intensified Production Of CAR-T Cells
4/18/2024
Achieving therapeutic doses in CAR-T cell therapies represents the longest phase of manufacturing. In this webinar, we explore scalable expansion processes designed to help meet growing demand.
-
Enhancing Efficiency And Accuracy In Cell Line Development
4/11/2024
Gain insights into the latest advancements in high-resolution multi-plane whole well imaging and the impact of AI-powered image analysis on clonality decisions and optimal clone selection.
-
Instant Implementation Of Raman-Based Monitoring
4/9/2024
This platform, based on Raman technology with a de novo approach, operates as effortlessly as a pH-meter, providing real-time measurements of key process parameters such as glucose, lactate, and biomass.
-
A Solution To Automate Concentration, Washing, And Medium Exchange
3/27/2024
Experience the assurance and peace of mind that come from utilizing a solution crafted to support the optimization and reliability of your operations.
-
A Closed And Automated Solution To Streamline Your Workflow
3/27/2024
Whether it's dilution, mixing, cryopreparation, or splitting of cellular products, ReadySelect offers a comprehensive solution for your up- or downstream cell therapy manufacturing workflow.
-
A Flexible Solution To Automate Concentration, Washing, And Formulation
3/27/2024
Enjoy the flexibility of user-definable parameters, allowing you to tailor each step of your process, including concentration via continuous flow, washing, resuspension, and final formulation.
-
Navigating Challenges In Immune Cell Therapy Analysis
3/27/2024
During this panel, experts discuss the challenges faced by developers and manufacturers in the immune cell therapy field. These challenges include scalability, regulatory hurdles, and data standardization.
-
Enhancing Quality By Employing Cell Line Replacement, Process Optimization
3/19/2024
Explore how the various proprietary platforms and in-house expertise fit together to enable a range of comprehensive options that can be adapted to fit development strategies.
-
GMP-Compliant Production Lines Of Plasmid
3/19/2024
The OBiO Intelli-M GMP manufacturing site has three production lines of prokaryotic cell culture plasmid for commercial manufacturing, including a single-use whole process production line and two stainless steel production lines.